While President Donald Trump may wish he lives and works in the Hogwarts School of Witchcraft and Wizardry and has Harry ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

Drugmakers Pfizer and Flynn Pharma have been ... so they were no longer subject to price regulations. Pfizer hiked the price of the drug between 780% and 1,600%, and also supplied the drug to ...

Pfizer Inc. today announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutical company, for the development, ...

Trump signed a similar executive order in the final weeks of his first term, but a court order later blocked the rule from ...

The US-UK trade deal gives the Irish government and EU negotiators some indication of the potential negotiating tactics to ...

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win over its rival. | A federal jury in Delaware has ...

Instead, said Kaitin, drugs hit the US market first because the sponsors choose to submit them there first. The advantage of the US is almost wholly down to its lack of price controls, says Kaitin.

The Pediatric Antibiotics Market comprises specialized formulations of beta-lactams, macrolides, cephalosporins, and sulfonamides designed to treat bacterial infections in infants and children. These ...

The order sets a 30-day deadline for drug companies to make "significant progress," or face further action such as tariffs, drug import policies, and pricing regulations ... with Merck rising 5.8%, ...